Major Shareholder Sapiens S.ar.l. Sells $133.5M in Shares, Exits Below 5% Ownership
CNXC is trading near its 52-week low of $22.85 (7.4% above the low) on elevated volume (2.8× avg).
Summary
Sapiens S.ar.l., a significant institutional investor, has sold 6 million shares of Concentrix Corp for $133.5 million, reducing its stake to 4.55% and ceasing to be a 5% beneficial owner.
Key Events · Ownership and Investor Activity · CNXC
-
Major Shareholder Sells Large Block
Sapiens S.ar.l. sold 6,000,000 shares of Common Stock on April 29, 2026.
-
Significant Transaction Value
The shares were sold at $22.25 per share, totaling $133.5 million.
-
Ownership Below 5% Threshold
Following the sale, the Reporting Persons (Groupe Bruxelles Lambert and its affiliates) now beneficially own 2,773,667 shares, representing 4.55% of outstanding shares, and have ceased to be a 5% owner.
-
Confirms Prior Intent to Sell
This filing confirms the execution of the sale previously indicated by a Form 144 filed on April 29, 2026.
Analysis · CNXC · Trade & Services
This Schedule 13D/A confirms the execution of a substantial block trade by Sapiens S.ar.l., an entity related to Groupe Bruxelles Lambert. The sale of 6 million shares, valued at $133.5 million, represents a significant reduction in their holdings (approximately 68% of their prior stake) and brings their ownership below the 5% threshold, removing their beneficial ownership reporting obligations. This transaction, following a Form 144 filing on April 29, 2026, signals a notable decrease in institutional conviction or a strategic portfolio rebalancing by a major investor. The sale price of $22.25 per share was below the current market price, suggesting a discount was offered to facilitate the large block trade. Investors should consider the implications of a major shareholder significantly reducing its position.
At the time of this filing, CNXC was trading at $24.53 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $1.5B. The 52-week trading range was $22.85 to $62.14. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.